Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Aim: The purpose of this study was to examine the phenotypic and genetic characteristics of patients with type 2 diabetes mellitus (T2DM) with different responses to treatment with metformin (MF) in the Novosibirsk region. Materials and methods: We examined 460 patients with T2DM in the Novosibirsk...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irina A. Bondar, Olesya Y. Shabelnikova, Ekaterina A. Sokolova, Olga V. Pyankova, Maksim L. Filipenko
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2016-05-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus metformin atm (rs11212617).
Online Access:	https://www.dia-endojournals.ru/jour/article/view/7227
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors associated with abnormal cardio-ankle vascular index in patients with type 2 diabetes and prediabetes
by: Aleksei N. Sumin, et al.
Published: (2016-05-01)

Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
by: Irina Arkad'evna Bondar, et al.
Published: (2015-03-01)

Relationship between the efficacy of sulfonylurea therapy and structural variants of the ABCC8 (rs757110) and KCNJ11 (rs5219) genes in patients with type 2 diabetes mellitus with different phenotypes
by: I. А. Bondar’, et al.
Published: (2024-04-01)

The Genetic Polymorphisms of rs161620 and rs2229611 in G6PC 3′UTR Are Associated With Metformin Efficacy in Chinese Type 2 Diabetes Mellitus
by: Cuilin Li, et al.
Published: (2025-04-01)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)

Risks of mortality for various phenotypes in patients with type 2 diabetes mellitus in the Novosibirsk region
by: I. A. Bondar, et al.
Published: (2025-01-01)

ATM rs189037 polymorphism: A potential genetic risk factor for sperm DNA damage and male infertility
by: Erdal Gülbahar Güzel, et al.
Published: (2025-07-01)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01)

Type 2 diabetes clusters in the Novosibirsk region
by: I. A. Bondar, et al.
Published: (2023-07-01)

Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017-08-01)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
by: Anna I. Sazonova, et al.
Published: (2016-05-01)

Gallic acid improves the metformin effects on diabetic kidney disease in mice
by: Yan Hong, et al.
Published: (2023-12-01)

PROBLEMS OF COMMERCIAL BANK ATM NETWORK FORMATION
by: J. V. Domashova
Published: (2017-10-01)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015-06-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

The effect of different concentrations of metformin in the liver and kidney functions for diabatic induced male rats.
by: Inas Mujil Nayef Al-janabi, et al.
Published: (2021-09-01)

Distribution of FoxP3+regulatoryT-cells in rat’spancreatic lymph nodes under streptozotocin-induced diabetes and metformin administration
by: D. A. Putilin, et al.
Published: (2015-04-01)

DIABETES MELLITUS TYPE 2 TREATMENT IN CHILDREN AND ADOLESCENTS: METFORMIN AS A FIRST AGENT OF CHOICE
by: T. L. Kuraeva
Published: (2012-01-01)

The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
by: K.A. Moskva, et al.
Published: (2024-06-01)

A review of metformin and its place in the diabetes guidelines
by: Gail Mkele
Published: (2013-12-01)

The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
by: Olga Mikhailovna Smirnova
Published: (2010-09-01)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
by: Lev Mikhaylovich Bershteyn, et al.
Published: (2014-03-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals
by: Xuguang Chen, et al.
Published: (2025-04-01)

An Updated Systematic Review and Meta‐Analysis on the Efficacy and Safety of Metformin as Add‐on Therapy to Insulin in Patients With Type 1 Diabetes
by: Mohammad Mahdi Masouri, et al.
Published: (2025-07-01)

Metformin's impact on asprosin and FBN1 expression: Potential mechanisms beyond insulin sensitivity in type 2 diabetes in rats
by: Ali Dashtkar, et al.
Published: (2025-01-01)

Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan
by: Arif Ullah Khan, et al.
Published: (2025-08-01)

Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
by: Lin Y, et al.
Published: (2025-03-01)

Role of Metformin in Reducing the Incidence of Gestational Diabetes Mellitus in Obese Women
by: Shazia Rasul, et al.
Published: (2024-12-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

Genetic framework of type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)

A comparative study between metformin and insulin on biochemical variables in diabetic patients
by: Maha Elttayef Jasim, et al.
Published: (2024-09-01)

Insulin resistance-induced mitochondrial dysfunction and pyroptosis in trophoblasts: protective role of metformin
by: Runyu Du, et al.
Published: (2025-03-01)

Role of Genetic and Environmental Factors in Determining the Response to Metformin
by: А. N. Kucher, et al.
Published: (2022-02-01)

Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
by: Ekaterina Nikodimovna Kravchuk, et al.
Published: (2013-03-01)

Pathogenetic basis of treating endothelial dysfunction with metformin in patients with diabetes (literature review and own data)
by: A.M. Sokolova, et al.
Published: (2024-05-01)

Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)

Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
by: Ni Nyoman Wahyu Udayani, et al.
Published: (2022-09-01)

Gestational Diabetes Management and Outcomes in South Jordan: Metformin Alone vs. Metformin-Insulin Therapy, A Retrospective Cohort Study
by: Ahlam M. Al-Kharabsheh, et al.
Published: (2024-11-01)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013-03-01)